loadpatents
name:-0.027391195297241
name:-0.012552976608276
name:-0.013821840286255
Kroth; Heiko Patent Filings

Kroth; Heiko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kroth; Heiko.The latest application filed is for "novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates".

Company Profile
11.15.24
  • Kroth; Heiko - Ecublens CH
  • Kroth; Heiko - 1024 Ecublens CH
  • Kroth; Heiko - Stadecken-Elsheim DE
  • Kroth; Heiko - Leimen DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gamma-carboline compounds for the detection of Tau aggregates
Grant 11,306,089 - Berndt , et al. April 19, 2
2022-04-19
Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
App 20210214371 - Nampally; Sreenivasachary ;   et al.
2021-07-15
Diagnostic Compositions For Pet Imaging, A Method For Manufacturing The Diagnostic Composition And Its Use In Diagnostics
App 20210047327 - CASTILLO MELEAN; Johnny ;   et al.
2021-02-18
Gamma-carboline Compounds For The Detection Of Tau Aggregates
App 20210047321 - BERNDT; Mathias ;   et al.
2021-02-18
Novel Method Of Preparing An Imaging Compound
App 20210038747 - ZERNA; Marion ;   et al.
2021-02-11
Azacarboline Compounds For The Detection Of Tau Aggregates
App 20210041447 - BERNDT; Mathias ;   et al.
2021-02-11
Compounds for imaging Tau protein aggregates
Grant 10,865,207 - Kroth , et al. December 15, 2
2020-12-15
Compounds for imaging Tau protein aggregates
Grant 10,835,624 - Kroth , et al. November 17, 2
2020-11-17
Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
Grant 10,662,193 - Kroth , et al.
2020-05-26
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
Grant 10,500,207 - Kroth , et al. Dec
2019-12-10
Compounds For Imaging Tau Protein Aggregates
App 20190263817 - KROTH; Heiko ;   et al.
2019-08-29
Compounds For Imaging Tau Protein Aggregates
App 20190262480 - KROTH; Heiko ;   et al.
2019-08-29
Novel Imaging Compounds
App 20180264146 - KROTH; Heiko ;   et al.
2018-09-20
2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
Grant 9,701,660 - Kroth , et al. July 11, 2
2017-07-11
Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins
App 20170002005 - KROTH; Heiko ;   et al.
2017-01-05
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
App 20160158242 - KROTH; Heiko ;   et al.
2016-06-09
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
Grant 9,221,812 - Kroth , et al. December 29, 2
2015-12-29
2,6-Diaminopyridine Compounds Suitable for Treating Diseases Associated with Amyloid or Amyloid-Like Proteins or for Treating or Preventing Ocular Diseases or Conditions Associated with a Pathological Abnormality/Change in the Tissue of the Visual System
App 20150023950 - Kroth; Heiko ;   et al.
2015-01-22
2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
Grant 8,916,590 - Kroth , et al. December 23, 2
2014-12-23
Heterobicyclic metalloprotease inhibitors
Grant 8,835,441 - Steeneck , et al. September 16, 2
2014-09-16
Heterobicyclic Metalloprotease Inhibitors
App 20120015920 - Steeneck; Christoph ;   et al.
2012-01-19
Dipeptidyl peptidase-IV inhibitors
Grant 8,076,330 - Kroth , et al. December 13, 2
2011-12-13
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
App 20110280808 - Kroth; Heiko ;   et al.
2011-11-17
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
App 20110256064 - Kroth; Heiko ;   et al.
2011-10-20
Dipeptidyl Peptidase-IV Inhibitors
App 20110112051 - KROTH; Heiko ;   et al.
2011-05-12
2,6-Diaminopyridine Compounds Suitable For Treating Diseases Associated With Amyloid Or Amyloid-Like Proteins Or For Treating Or Preventing Ocular Diseases Or Conditions Associated With A Pathological Abnormality/Change In The Tissue Of The Visual System
App 20110092537 - Kroth; Heiko ;   et al.
2011-04-21
Heterobicyclic metalloprotease inhibitors
Grant 7,795,245 - Steeneck , et al. September 14, 2
2010-09-14
Dipeptidyl Peptidase-iv Inhibitors
App 20100009961 - Kroth; Heiko ;   et al.
2010-01-14
Heterobicyclic Metalloprotease Inhibitors
App 20090312312 - STEENECK; Christoph ;   et al.
2009-12-17
Dipeptidyl peptidase-IV inhibitors
Grant 7,553,861 - Kroth , et al. June 30, 2
2009-06-30
Heterobicyclic metalloprotease inhibitors
App 20080221092 - Bluhm; Harald ;   et al.
2008-09-11
Heterobicyclic metalloprotease inhibitors
App 20080221083 - Hochgurtel; Matthias ;   et al.
2008-09-11
Heterobicyclic metalloprotease inhibitors
App 20080161300 - Steeneck; Christoph ;   et al.
2008-07-03
Heterobicyclic metalloprotease inhibitors
App 20070155738 - Steeneck; Christoph ;   et al.
2007-07-05
Heterobicyclic metalloprotease inhibitors
App 20060293345 - Steeneck; Christoph ;   et al.
2006-12-28
Dipeptidyl peptidase-IV inhibitors
App 20060270701 - Kroth; Heiko ;   et al.
2006-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed